Abstract

Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate?

Author(s): Tan Robert S

Issue: Nov/Dec 2004 - Endotoxin

Page(s): 419-423

Download in electronic PDF format for $75
  • Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate? Page 1
  • Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate? Page 2
  • Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate? Page 3
  • Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate? Page 4
  • Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate? Page 5

Abstract

Clinicians are confronted daily with patients whose symptoms suggest low levels of sex hormones such as testosterone. Testosterone deficiency may result from a variety of conditions from pituitary tumor to age-related decline in testosterone production (andropause). Diagnosis of low testosterone may be complicated by obesity, depression, diabetes and other chronic diseases, certain medications, and other factors. A range of both serum and saliva tests are available to test testosterone levels, but the best laboratory method for confirming testosterone deficiency is controversial. The results of saliva testing, if performed correctly, have been shown to correlate well with those of serum testing. Despite its greater comfort and convenience and lower cost, however, saliva testing has not yet been accepted into mainstream medicine. Measuring testosterone level is complicated by the fact that hormone release is cyclical and is influenced by many factors, including stress, age, and time of day. Which test result(s) best represents a patient’s true testosterone status has not been resolved. Furthermore, research has shown that sex hormone levels do not correlate well with symptoms. The clinician should rely on both clinical assessment and laboratory data to identify the “normal” testosterone level for each individual, using a concept the author describes as “relative hypogonadism” to determine which patients require testosterone supplementation.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2004
Pg. 419-423
Author(s): Tan Robert S
Sep/Oct 2009
Pg. 392-399
Jan/Feb 2001
Pg. 52-54
Author(s): Ford Gina, Garcia Lea
Jul/Aug 2009
Pg. 280-288
Mar/Apr 2011
Pg. 102-112
Jul/Aug 2009
Pg. 276-279
Author(s): Biundo Bruce
Jan/Feb 2024
Pg. 28-32
Author(s): Biundo Bruce
May/Jun 2004
Pg. 175-178
Author(s): Biundo Bruce
Jul/Aug 2019
Pg. 325-339
Jan/Feb 2004
Pg. 16-21
Nov/Dec 2000
Pg. 429-431
May/Jun 2015
Pg. 252-260
Mar/Apr 2008
Pg. 122-127
Nov/Dec 2009
Pg. 494-496
Author(s): Biundo Bruce
Nov/Dec 2000
Pg. 421-422
Author(s): Ford Gina, Garcia Lea
Sep/Oct 2001
Pg. 342-344
Author(s): Collins Joseph J
Jan/Feb 2013
Pg. 28-38
Author(s): Biundo Bruce
Jan/Feb 2024
Pg. 6-14
Author(s): Biundo Bruce
May/Jun 2015
Pg. 195-203
Author(s): Guth Michael AS
Jul/Aug 2013
Pg. 307-311
Author(s): McElhiney Linda F